Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

EntreMed produces recombinant Angiostatin

April 22, 1997

ProScript licenses cell cycle regulation technology from Harvard Medical School

April 22, 1997

ImmunoGen's novel anticancer agent eradicates a human cancer in mice

April 22, 1997

Yamanouchi describes potent and selective steroid 17,20 lyase inhibitor

April 22, 1997

Princeton and Lilly disclose nonclassical antifolates

April 22, 1997

Alfacell elucidates action of Onconase

April 22, 1997

PLC-inhibitory peptides from Kyowa Hakko

April 22, 1997

Inflazyme licences anticancer drugs

April 21, 1997

Antimetastatic activity of Neovastat reported at AACR meeting

April 21, 1997

Antitumor/antibacterial agent isolated by Microbial Chemistry Research Foundation

April 21, 1997

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...